Patents by Inventor Yael Spector

Yael Spector has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MIRNA EXPRESSION SIGNATURE IN THE CLASSIFICATION OF THYROID TUMORS
    Publication number: 20190300963
    Abstract: The present invention provides a method for classification of thyroid tumors through the analysis of the expression patterns of specific microRNAs in fine needle aspiration samples. Thyroid tumor classification according to a microRNA expression signature allows optimization of diagnosis and treatment, as well as determination of signature-specific therapy.
    Type: Application
    Filed: November 15, 2018
    Publication date: October 3, 2019
    Applicant: ROSETTA GENOMICS LTD.
    Inventors: Zohar Barnett-Itzhaki, Gila Lithwick Yanai, Eti Meiri, Yael Spector, Hila Benjamin, Nir Dromi
  • MIRNA EXPRESSION SIGNATURE IN THE CLASSIFICATION OF THYROID TUMORS
    Publication number: 20170356055
    Abstract: The present invention provides a method for classification of thyroid tumors through the analysis of the expression patterns of specific microRNAs in fine needle aspiration samples. Thyroid tumor classification according to a microRNA expression signature allows optimization of diagnosis and treatment, as well as determination of signature-specific therapy.
    Type: Application
    Filed: June 16, 2017
    Publication date: December 14, 2017
    Inventors: Zohar Barnett-Itzhaki, Gila Lithwick Yanai, Eti Meiri, Yael Spector, Hila Benjamin, Nir Dromi
  • MiRNA expression signature in the classification of thyroid tumors
    Patent number: 9708667
    Abstract: The present invention provides a method for classification of thyroid tumors through the analysis of the expression patterns of specific microRNAs in fine needle aspiration samples. Thyroid tumor classification according to a microRNA expression signature allows optimization of diagnosis and treatment, as well as determination of signature-specific therapy.
    Type: Grant
    Filed: August 15, 2016
    Date of Patent: July 18, 2017
    Assignee: ROSETTA GENOMICS, LTD.
    Inventors: Gila Lithwick Yanai, Eti Meiri, Yael Spector, Hila Benjamin, Nir Dromi
  • MIRNA EXPRESSION SIGNATURE IN THE CLASSIFICATION OF THYROID TUMORS
    Publication number: 20170016076
    Abstract: The present invention provides a method for classification of thyroid tumors through the analysis of the expression patterns of specific microRNAs in fine needle aspiration samples. Thyroid tumor classification according to a microRNA expression signature allows optimization of diagnosis and treatment, as well as determination of signature-specific therapy.
    Type: Application
    Filed: August 15, 2016
    Publication date: January 19, 2017
    Inventors: Zohar Barnett-Itzhaki, Gila Lithwick Yanai, Eti Meiri, Yael Spector, Hila Benjamin, Nir Dromi
  • Gene expression signature for classification of kidney tumors
    Patent number: 9340823
    Abstract: The present invention provides a method for classification of kidney tumors through the analysis of the expression patterns of specific microRNAs and nucleic acid molecules relating thereto. Classification according to a microRNA expression framework allows optimization of treatment, and determination of specific therapy.
    Type: Grant
    Filed: January 30, 2014
    Date of Patent: May 17, 2016
    Assignees: Rosetta Genomics, Ltd., Tel Hashomer Medical Research Infrastructure and Services Ltd.
    Inventors: Nitzan Rosenfeld, Yael Spector, Eddie Friedman, Zohar Dotan
  • Gene expression signature for classification of kidney tumors
    Patent number: 9068232
    Abstract: The present invention provides a method for classification of kidney tumors through the analysis of the expression patterns of specific microRNAs and nucleic acid molecules relating thereto. Classification according to a microRNA expression framework allows optimization of treatment, and determination of specific therapy.
    Type: Grant
    Filed: March 5, 2012
    Date of Patent: June 30, 2015
    Assignees: Rosetta Genomics Ltd., Tel Hashomer Medical Research Infrastructure and Services Ltd.
    Inventors: Nitzan Rosenfeld, Yael Spector, Eddie Friedman, Zohar Dotan, Shai Rosenwald
  • Composition and methods for modulating cell proliferation and cell death
    Patent number: 9006206
    Abstract: Described herein are compositions and methods for modulation of p53-dependent cell death and cell proliferation. The compositions are microRNAs and associated nucleic acids.
    Type: Grant
    Filed: May 19, 2014
    Date of Patent: April 14, 2015
    Assignees: Rosetta Genomics Ltd., Yeda Research and Development Company Ltd.
    Inventors: Moshe Oren, Nina Raver-Shapira, Efi Marciano, Yael Spector
  • COMPOSITION AND METHODS FOR MODULATING CELL PROLIFERATION AND CELL DEATH
    Publication number: 20140256789
    Abstract: Described herein are compositions and methods for modulation of p53-dependent cell death and cell proliferation. The compositions are microRNAs and associated nucleic acids.
    Type: Application
    Filed: May 19, 2014
    Publication date: September 11, 2014
    Applicants: YEDA RESEARCH AND DEVELOPMENT COMPANY LTD., ROSETTA GENOMICS, LTD.
    Inventors: Moshe Oren, Nina Raver-Shapira, Efi Marciano, Yael Spector
  • GENE EXPRESSION SIGNATURE FOR CLASSIFICATION OF KIDNEY TUMORS
    Publication number: 20140243230
    Abstract: The present invention provides a method for classification of kidney tumors through the analysis of the expression patterns of specific microRNAs and nucleic acid molecules relating thereto. Classification according to a microRNA expression framework allows optimization of treatment, and determination of specific therapy.
    Type: Application
    Filed: January 30, 2014
    Publication date: August 28, 2014
    Applicants: Tel Hashomer Medical Research Infrastructure and Services Ltd., Rosetta Genomics Ltd.
    Inventors: Nitzan ROSENFELD, Yael Spector, Eddie Friedman, Zohar Dotan
  • Composition and methods for modulating cell proliferation and cell death
    Patent number: 8765702
    Abstract: Described herein are compositions and methods for modulation of p53-dependent cell death and cell proliferation. The compositions are microRNAs and associated nucleic acids.
    Type: Grant
    Filed: February 26, 2008
    Date of Patent: July 1, 2014
    Assignees: Rosetta Genomics Ltd., Yeda Research and Development Company Ltd.
    Inventors: Moshe Oren, Nina Raver-Shapira, Efi Marciano, Yael Spector
  • GENE EXPRESSION SIGNATURE FOR CLASSIFICATION OF KIDNEY TUMORS
    Publication number: 20120157344
    Abstract: The present invention provides a method for classification of kidney tumors through the analysis of the expression patterns of specific microRNAs and nucleic acid molecules relating thereto. Classification according to a microRNA expression framework allows optimization of treatment, and determination of specific therapy.
    Type: Application
    Filed: March 5, 2012
    Publication date: June 21, 2012
    Inventors: NITZAN ROSENFELD, YAEL SPECTOR, EDDIE FRIEDMAN, ZOHAR DOTAN, SHAI ROSENWALD
  • GENE EXPRESSION SIGNATURE FOR CLASSIFICATION OF KIDNEY TUMORS
    Publication number: 20110160086
    Abstract: The present invention provides a method for classification of kidney tumors through the analysis of the expression patterns of specific microRNAs and nucleic acid molecules relating thereto. Classification according to a microRNA expression framework allows optimization of treatment, and determination of specific therapy.
    Type: Application
    Filed: August 5, 2009
    Publication date: June 30, 2011
    Inventors: Nitzan Rosenfeld, Yael Spector, Eddie Friedman, Zohar Dotan
  • COMPOSITION AND METHODS FOR MODULATING CELL PROLIFERATION AND CELL DEATH
    Publication number: 20100104662
    Abstract: Described herein are compositions and methods for modulation of p53-dependent cell death and cell proliferation. The compositions are microRNAs and associated nucleic acids.
    Type: Application
    Filed: February 26, 2008
    Publication date: April 29, 2010
    Inventors: Moshe Oren, Nina Raver-Shapira, Efi Marciano, Yael Spector